Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
2,503 results
  • Mirtazapine for symptom control in refractory gastroparesis. [Journal Article]
  • DDDrug Des Devel Ther 2017; 11:1035-1041
  • Malamood M, Roberts A, … Schey R
  • CONCLUSIONS: Mirtazapine significantly improved both nausea and vomiting in gastroparetics after 2 and 4 weeks of treatment. Side effects led to treatment self-cessation in a fifth of patients. From these data, we conclude that mirtazapine improves nausea and vomiting, among other symptoms, in patients with gastroparesis and might be useful in select patients.
  • Therapeutic Potential of Targeting the Ghrelin Pathway. [Review]
  • IJInt J Mol Sci 2017 Apr 11; 18(4)
  • Colldén G, Tschöp MH, Müller TD
  • Ghrelin was discovered in 1999 as the endogenous ligand of the growth-hormone secretagogue receptor 1a (GHSR1a). Since then, ghrelin has been found to exert a plethora of physiological effects that g...
New Search Next